Validated RP-HPLC Method for Simultaneous Determination of Ribavirin, Sofosbuvir and Daclatasvir in Human Plasma: A Treatment Protocol Administered to HCV Patients in Egypt
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validated RP-HPLC Method for Simultaneous Determination of Ribavirin, Sofosbuvir and Daclatasvir in Human Plasma: A Treatment Protocol Administered to HCV Patients in Egypt
Authors
Keywords
-
Journal
JOURNAL OF CHROMATOGRAPHIC SCIENCE
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-04-06
DOI
10.1093/chromsci/bmz038
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study
- (2018) Ola M. Abdallah et al. BIOMEDICAL CHROMATOGRAPHY
- Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience
- (2018) G. Shiha et al. Hepatology International
- Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions
- (2018) Silva P. Kouyoumjian et al. Scientific Reports
- Novel and sensitive UPLC-MS/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study
- (2016) Mamdouh R. Rezk et al. BIOMEDICAL CHROMATOGRAPHY
- Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study
- (2016) Chenwei Pan et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Development and validation of sensitive and rapid UPLC–MS/MS method for quantitative determination of daclatasvir in human plasma: Application to a bioequivalence study
- (2016) Mamdouh R. Rezk et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma
- (2016) Alessandra Ariaudo et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment
- (2016) Amr Kandeel et al. LIVER INTERNATIONAL
- Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
- (2015) Brian J. Kirby et al. CLINICAL PHARMACOKINETICS
- Daclatasvir: A Review of Its Use in Adult Patients with Chronic Hepatitis C Virus Infection
- (2015) Paul L. McCormack DRUGS
- Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS
- (2015) Xiaojun Shi et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study
- (2015) Mamdouh R. Rezk et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
- (2015) Mirjam Zeisel et al. Viruses-Basel
- Validated Stability-Indicating Liquid Chromatographic Method for the Determination of Ribavirin in the Presence of Its Degradation Products: Application to Degradation Kinetics
- (2014) F. Belal et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Stability-Indicating HPLC-DAD Determination of Ribavirin in Capsules and Plasma
- (2013) R. S. Haggag et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Development and validation of a useful UPLC–MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients
- (2013) Danilo Agnesod et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- New US FDA draft guidance on bioanalytical method validation versus current FDA and EMA guidelines: chromatographic methods and ISR
- (2013) Dieter Zimmer Bioanalysis
- A sensitive and accurate liquid chromatography–tandem mass spectrometry method for quantitative determination of the novel hepatitis C NS5A inhibitor BMS-790052 (daclastasvir) in human plasma and urine
- (2012) Hao Jiang et al. JOURNAL OF CHROMATOGRAPHY A
- Development and validation of a useful HPLC–UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients
- (2012) Antonio D’Avolio et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients
- (2011) A. A. Butt et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More